Literature DB >> 154293

Acromegaly and the heart. An echocardiographic study.

R C Smallridge, S Rajfer, J Davia, M Schaaf.   

Abstract

Twenty-seven patients with acromegaly had echocardiograms performed to delineate the ventricular septum, left ventricular posterior wall and mitral valve. Left ventricular function was assessed by calculating the systolic internal dimensional shortening of the left ventricle. Six patients met the criteria for asymmetric septal hypertrophy and eight had concentric left ventricular hypertrophy. The remaining 13 patients were categorized as "normal," although six had septal measurements greater than 11 mm. The group with asymmetric septal hypertrophy had significantly greater percentage of internal dimensional shortening during systole than either the normal group (p less than 0.05) or the group with left ventricular hypertrophy (p less than 0.01). Initial mean growth hormone levels were considerably higher in the group with left ventricular hypertrophy than in the normal group (93 versus 34 ng/ml). Thus, echocardiographic abnormalities are common in acromegaly, and patients with asymmetric septal hypertrophy and acromegaly appear to have significantly increased ventricular ejection. Many of the patients with left ventricular hypertrophy have no evidence of clinical cardiovascular disease, and their left ventricular hypertrophy may be related to higher initial growth hormone levels.

Entities:  

Mesh:

Year:  1979        PMID: 154293     DOI: 10.1016/0002-9343(79)90477-7

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  17 in total

1.  Doppler echocardiographic patterns in patients with acromegaly.

Authors:  M Terzolo; L Avonto; C Matrella; R Pozzi; S Luceri; G Borretta; F Pecchio; G Ugliengo; G P Magro; G Reimondo
Journal:  J Endocrinol Invest       Date:  1995-09       Impact factor: 4.256

2.  Left ventricular volume and mass in children on growth hormone therapy compared with untreated children.

Authors:  D Heuschmann; O Butenandt; M Vogel
Journal:  Eur J Pediatr       Date:  1996-02       Impact factor: 3.183

3.  Growth hormone status predicts left ventricular mass in patients after cure of acromegaly.

Authors:  Tamara L Wexler; Ronen Durst; David McCarty; Michael H Picard; Lindsay Gunnell; Zehra Omer; Pouneh Fazeli; Karen K Miller; Anne Klibanski
Journal:  Growth Horm IGF Res       Date:  2010-07-03       Impact factor: 2.372

4.  Acromegalic cardiomyopathy. An echocardiographic study.

Authors:  L Lusiani; G Ronsisvalle; A Visonà; V Castellani; A Bonanome; A Pagnan; F Facchin; N Sicolo; G Federspil
Journal:  J Endocrinol Invest       Date:  1988-03       Impact factor: 4.256

5.  Acromegalic cardiomyopathy: evaluation of the left ventricular diastolic function in the subclinical stage.

Authors:  N Ozbey; A Oncül; Z Buğra; A Vural; F Erzengin; Y Orhan; K Büyüköztürk; E Sencer; S Molvalilar
Journal:  J Endocrinol Invest       Date:  1997-06       Impact factor: 4.256

6.  The GH/IGF-1 Axis and Heart Failure.

Authors:  Graziella Castellano; Flora Affuso; Pasquale Di Conza; Serafino Fazio
Journal:  Curr Cardiol Rev       Date:  2009-08

7.  Acromegalic cardiopathy: a left ventricular scintigraphic study.

Authors:  N Sicolo; F Bui; M Sicolo; L Varotto; C Martini; C Macor; G Federspil
Journal:  J Endocrinol Invest       Date:  1993-02       Impact factor: 4.256

8.  Gross aortic root dilation in a young woman with acromegaly.

Authors:  Andrew Wiper; M Eisenberger; A McPartlin; M El-Omar
Journal:  Exp Clin Cardiol       Date:  2012

9.  Cardiovascular effects of high-dose growth hormone treatment in growth hormone-deficient children.

Authors:  R Crepaz; W Pitscheider; G Radetti; C Paganini; L Gentili; G Morini; E Braito; G Mengarda
Journal:  Pediatr Cardiol       Date:  1995 Sep-Oct       Impact factor: 1.655

10.  Relation of endocrine and cardiac findings in acromegalics.

Authors:  G Kahaly; C Stover; J Beyer; S Mohr-Kahaly
Journal:  J Endocrinol Invest       Date:  1992-01       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.